IL22 and inflammatory bowel disease: Experimental studies on IBD have shown an increase in these immune cell populations together with an increased secretion of proinflammatory cytokines, of which IL-6, IL-13, IL-17, IL-22, and IL-23 proved to have an important share in the evolution of IBD.